Advertisement

Digestive Diseases and Sciences

, Volume 49, Issue 9, pp 1425–1432 | Cite as

Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease?

  • Christelle Basset
  • John Holton
  • Alexandra Bazeos
  • Dino Vaira
  • Stuart Bloom
Article

Abstract

The aim of this study was to determine if either Helicobacter or enterotoxigenic Bacteroides fragilis (ETBF) was linked to inflammatory bowel disease (IBD), using PCR. We analyzed the luminal washings and colonic biopsies of 35 patients with IBD and 37 control patients. The presence of Helicobacter was confirmed in the luminal washing of one IBD patient and three control patients and in the biopsies of two IBD patients. Ten of 28 control patients and 8 of 32 IBD patients had a positive luminal washing for the enterotoxin gene. Six of 33 control patients and 4 of 32 IBD patients had positive biopsies. The prevalence of the enterotoxin gene was higher in IBD patients with active disease compared with patients with inactive disease, although it did not achieve statistical significance. In conclusion, Helicobacter was not associated with IBD in our population of patients, although ETBF may be associated with active disease.

Helicobacter Bacteroides IBD diarrhea 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Hendrickson BA, Gokhale R, Cho JH: Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15:79–94, 2002Google Scholar
  2. 2.
    Basset C, Holton J: Inflammatory bowel disease: Is the intestine a Trojan Horse? Sci Prog 85:33–56, 2002Google Scholar
  3. 3.
    Hermiston ML, Gordon JI: Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270(1203):12–17, 1995Google Scholar
  4. 4.
    Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102:448–455, 1995Google Scholar
  5. 5.
    Neurath MF, Finotto S, Fuss I, Boirivant M, Galle PR, W. Strober W: Regulation of T cell apoptosis in IBD: To die or not to die that is the mucosal question. Trends Immunol 22:21–26, 2001Google Scholar
  6. 6.
    Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, Scholmerich J, Sartor RB: Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 69:2277–2285, 2001Google Scholar
  7. 7.
    Wei B, Huang T, Dalwadi H, Sutton CL, Bruckner D, and Braun J: Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect Immun 70:6567–6575, 2002Google Scholar
  8. 8.
    Kent KA, Sellwood R, Lemcke RM, Burrows MR, and Lysons RJ: Analysis of the axial filaments of Treponema hyodysenteriae by SDS-PAGE and immunoblotting. J Gen Microbiol 135:1625–1632, 1989Google Scholar
  9. 9.
    Campieri M, Gionchetti P: Bacteria as the cause of ulcerative colitis. Gut 48:132–135, 2001Google Scholar
  10. 10.
    Martin HM, Rhodes JM: Bacteria and inflammatory bowel disease. Curr Opin Infect Dis 13:503–509, 2000Google Scholar
  11. 11.
    Hubbard J, Surawiczcm M: Etiological role of Mycobacterium in Crohn's disease: an assessment of the literature. Dig Dig Sci 17:6–13, 1999Google Scholar
  12. 12.
    Stallmach A, Carstens O: Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm Bowel Dis 8:213–218, 2002Google Scholar
  13. 13.
    Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF: Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115:1405–1413, 1998Google Scholar
  14. 14.
    San Joaquin VH, Griffis JC, Lee C, Sears CL: Association of Bacteroides fragilis in childhood diarrhoea. Scand J Infect Dis 27:211–215, 1995Google Scholar
  15. 15.
    Pantosti A, Menozzi MG, Frate A, Sanfilippo L, D'Ambrosio F, Malpeli M: Detection of enterotoxigenic Bacteroides fragilis and its toxin in stool samples from adults and children in Italy. Clin Infect Dis 24:12–16, 1997Google Scholar
  16. 16.
    Meisel-Mikolajczyk F, Podsiadly E, Rouyan GS: Enterotoxigenic Bacteroides fragilis isolated from non-diarrhoeic adults. Acta Microbiol Pol 45;181–186, 1996Google Scholar
  17. 17.
    Shetab R, Cohen SH, Prindiville T, Tang YJ, Cantrell M, Rahmani D, Silva J Jr: Detection of Bacteroides fragilis enterotoxin gene by PCR. J Clin Microbiol 36:1729–1732, 1998Google Scholar
  18. 18.
    Pantosti A, Malpeli M, Wilks M, Menozzi MG, D'Ambrosio F: Detection of enterotoxigenic Bacteroides fragilis by PCR. J Clin Microbiol 35:2482–2486, 1997Google Scholar
  19. 19.
    Prindiville TP, Sheikh RA, Cohen SH, Tang YT, Cantrell MC, Silva J Jr: Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 6:171–174, 2000Google Scholar
  20. 20.
    Gasbarrini A, Franceschi F, Armuxxi A, Ojetti V, Candelli M, Torre ES, De Lorenzo A, Anti M, Pretolani S, Gasbarrini G: Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 45 (Suppl I):I9–I12, 1999Google Scholar
  21. 21.
    Triantafillidis JK, Gikas A, Apostolidiss N, Merikas E, Mallass E, Peros G: The low prevalence of Helicobacter infection in patients with IBD could be attributed to previous antibiotic treatment. Am J Gastroenterol 98:1213–1314, 2003Google Scholar
  22. 22.
    Halme L, Rautelin H, Leidenius M, Kosunen TU: Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol 49:65–67, 1996Google Scholar
  23. 23.
    Oliveira AG, Sanna MP, Cunha LPF, Rocha GA, Rocha AMC, Moura SB, Santos A, Ferrari MA, Dani R, Marinho FP, Moreira LS, Camargo E, Queiroz DMM: Crohn's disease (CD) and Helicobacter species in the intestinal mucosa. Helicobacter 8:446, 2003Google Scholar
  24. 24.
    O'Rourke JL, Grehan M, Lee A: Non-pylori Helicobacter species in humans. Gut 49:601–606, 2001Google Scholar
  25. 25.
    Shomer NH, Dangler CA, Schrenzel MD, Fox JG: Helicobacter bilis-induced inflammatory bowel disease in SCID mice with defined flora. Infect Immun 65:4858–4864, 1997Google Scholar
  26. 26.
    Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A: Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12-and gamma interferon-dependent mechanism. Infect Immun 66:5157–5166, 1998Google Scholar
  27. 27.
    Danon SJ, Goh KL, Parasakthi N, Parasakthi N, Neilan BA, Grehan MJ, Lee A: The human colon: A reservoir for Helicobacter species. Gut 47:A2, 2000Google Scholar
  28. 28.
    Grehan MJ, Danon SJ: Absence of Helicobacter species in the ileum and colon of Australians with or without inflammatory bowel disease (IBD)—Should we be looking at other mucus-associated bacteria. Gastroenterology 120 (Suppl 1):A–337, 2001Google Scholar
  29. 29.
    Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA: Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther 18:481–486, 2003Google Scholar
  30. 30.
    Bohr URM, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P: Enterohepatic Helicobacter species and inflammatory bowel diseases. In: Falk Symposium. Mechanisms of Intestinal Inflammation: Implications for Therapeutic Intervention in IBD, Berlin (Germany), June 10–11, 2003, Vol 133, p. 3Google Scholar
  31. 31.
    Gramley WA, Asghar A, Frierson HF, Powel SMl: Detection of Helicobacter pylori DNAin fecal samples from infected individuals. J Clin Microbiol 37:2236–2240, 1999Google Scholar
  32. 32.
    Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, Roa I: Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114:755–763, 1998Google Scholar
  33. 33.
    Lu JJ, Perng CL, Shyru RY, Chen CH, Lou Q, Chong SK, Lee CH: Comparison of five methods for detection of Helicobacter pylori DNA in gastric tissues. J Clin Microbiol 37:772–774, 1999Google Scholar
  34. 34.
    Sanfilippo L, Baldwin TJ, Menozzi MG, Borriello SP, Mahida YR: Heterogeneity in responses by primary adult human colonic epithelial cells to purified enterotoxin of Bacteroides fragilis. Gut 43:651–655, 1998Google Scholar
  35. 35.
    Wells CL, van de Westerlo EM, Jechorek RP, Feltis BA, Wilkins TD, Erlandsen SL: Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalisation by HT-29 enterocytes. Gastroenterology 110:1429–1437, 1996Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • Christelle Basset
    • 1
  • John Holton
    • 1
  • Alexandra Bazeos
    • 1
  • Dino Vaira
    • 2
  • Stuart Bloom
    • 2
  1. 1.Centre for Infectious Diseases and International HealthRoyal Free & University College London Medical SchoolLondonUnited Kingdom
  2. 2.Department of Internal Medicine and GastroenterologyUniversity of BolognaBolognaItaly

Personalised recommendations